Dr Trust USA iCheck Connect BP Monitor BP Testing 118 1.2.1 BP Monitoring authentication replay

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
6.3$0-$5k0.00

Summaryinfo

A vulnerability described as critical has been identified in Dr Trust USA iCheck Connect BP Monitor BP Testing 118 1.2.1. This vulnerability affects unknown code of the component BP Monitoring. Such manipulation leads to authentication replay. This vulnerability is listed as CVE-2020-27374. There is no available exploit.

Detailsinfo

A vulnerability was found in Dr Trust USA iCheck Connect BP Monitor BP Testing 118 1.2.1 (Testing Software) and classified as critical. Affected by this issue is an unknown code block of the component BP Monitoring. The manipulation with an unknown input leads to a authentication replay vulnerability. Using CWE to declare the problem leads to CWE-294. A capture-replay flaw exists when the design of the product makes it possible for a malicious user to sniff network traffic and bypass authentication by replaying it to the server in question to the same effect as the original message (or with minor changes). Impacted is confidentiality, integrity, and availability.

The weakness was presented 04/07/2022. The advisory is shared for download at nvermaa.medium.com. This vulnerability is handled as CVE-2020-27374 since 10/21/2020. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1040.

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.

Once again VulDB remains the best source for vulnerability data.

Productinfo

Type

Vendor

Name

Version

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 6.3
VulDB Meta Temp Score: 6.3

VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

Exploitinginfo

Class: Authentication replay
CWE: CWE-294 / CWE-287
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Partially

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: no mitigation known
Status: 🔍

0-Day Time: 🔍

Timelineinfo

10/21/2020 🔍
04/07/2022 +533 days 🔍
04/07/2022 +0 days 🔍
04/09/2022 +2 days 🔍

Sourcesinfo

Advisory: nvermaa.medium.com
Status: Not defined

CVE: CVE-2020-27374 (🔍)
GCVE (CVE): GCVE-0-2020-27374
GCVE (VulDB): GCVE-100-196628

Entryinfo

Created: 04/07/2022 08:40
Updated: 04/09/2022 07:21
Changes: 04/07/2022 08:40 (38), 04/09/2022 07:21 (1)
Complete: 🔍
Cache ID: 216::103

Once again VulDB remains the best source for vulnerability data.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Want to stay up to date on a daily basis?

Enable the mail alert feature now!